General: This presentation (“Presentation”) has been compiled by Hemp for Health Inc. (“Hemp for Health”) solely for information purposes. The presentation is not, and under no circumstances is to be construed to be, an offering of securities. Neither this presentation, nor its delivery to the recipient shall constitute an offer to sell, or the solicitation of an offer to buy the assets described herein. It is provided solely for use by prospective investors in considering their interest. No sales of the securities of Hemp for Health shall be made until Hemp for Health and the potential investor enter into a subscription agreement for such securities. The information contained herein has been prepared to assist interested parties in making their own evaluation of Hemp for Health and its business and does not purport to contain all the information that prospective investors may require. Prospective investors should conduct their own investigation and analysis of Hemp for Health and its business and the information contained in this presentation as well as any additional information provided by Hemp for Health. The information contained in this presentation is not to be used for any other purpose. Certain statutory rights for Canadian investors and key business and industry risk factors are included near the end of the presentation. Market Data and Industry Data: Market data and industry forecasts used in this Presentation were obtained from government or other industry publications, various publicly available sources or based on estimates derived from such publications and reports and management’s knowledge of, and experience in, the markets in which Hemp for Health operates. Government and industry publications and reports generally indicate that they have obtained their information from sources believed to be reliable, but do not guarantee the accuracy and completeness of their information. Actual outcomes may vary materially from those forecast in such reports or publications, and the prospect for material variation can be expected to increase as the length of the forecast period increases. Although Hemp for Health believes that these sources are generally reliable, the accuracy and completeness of such information are not guaranteed and have not been independently verified. Further, market and industry data is subject to variations and cannot be verified due to limits on the availability and reliability of data inputs, the voluntary nature of the data gathering process and other limitations and uncertainties inherent in any statistical survey. United States Matters: The securities described herein have not been or will not be registered under the United States Securities Act of 1933, as amended, or any U.S. state securities laws. Any securities offered will be offered only to qualified investors under exemptions from such registration requirements by subscription agreement. This Presentation does not constitute an offer of securities, and no offer or sale of securities will be conducted in any jurisdiction where such offer or sale is prohibited. Cautionary Note to European Investors: European laws, regulations and their enforcement, particularly those pertaining to anti-money laundering, relating to making and/or holding investments in cannabis- related practices or activities are in flux and vary dramatically from jurisdiction to jurisdiction. The enforcement of these laws – some of which carry criminal liability - and their effect on shareholders are uncertain and involve considerable risk. Accordingly, all potential investors located in Europe (including without limitation, the United Kingdom) should obtain their own, independent legal advice based on their own circumstances prior to making any investment in Hemp for Health (whether directly or indirectly, or acting on an agency or principal basis). Cautionary Note Regarding Forward Looking Statements: This presentation includes certain statements and information that constitute forward-looking information within the meaning of applicable Canadian securities laws, including statements regarding the approval of CBD by the US Food and Drug Administration will lead to validation of CBD therapeutic efficacy, the projected value of the CBD market worldwide over the next two years, the expected production capacity of Hemp for Health’s facilities, and Hemp for Health’s anticipated rollout of operations and sales. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as “intends” or “anticipates”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “should” or “would” occur. Forward-looking statements are based on certain material assumptions and analysis made by Hemp for Health and the opinions and estimates of management as of the date of this presentation, including that approval of CBD by the US Food and Drug Administration will lead to validation of CBD therapeutic efficacy, the projected value of the CBD market worldwide will be as anticipated by Cannabis Newswire, the expected production capacity of Hemp for Health’s facilities will be as anticipated by management, management’s assessment of the anticipated production cost over the next three years for Hemp for Health’s facility is accurate, management’s assessment of Hemp for Health’s anticipated revenue over the next three years is accurate and will be unaffected by any changes in the CBD market and Hemp for Health’s anticipated rollout of operations will be as anticipated by management. Although Hemp for Health considers these assumptions to be reasonable based on information currently available to it, they may prove to be incorrect, and the forward-looking statements in this release are subject to numerous risks, uncertainties and other factors that may cause future results to differ materially from those expressed or implied in such forward-looking statements. Such risk factors may include, among others, that approval of CBD by the US Food and Drug Administration will not lead to validation of CBD therapeutic efficacy, but rather will result in evidence that CBD does not have therapeutic efficacy, the projected value of the CBD market worldwide will not be as anticipated by Cannabis Newswire, or other listed sources, the expected production capacity of Hemp for Health’s facilities will not be as anticipated by management, management’s assessment of the anticipated production cost over the next three years for Hemp for Health’s facility is not accurate, management’s assessment of Hemp for Health’s anticipated revenue over the next three years is not accurate and Hemp for Health’s anticipated rollout of operations will not be as anticipated by management. Although management of Hemp for Health has attempted to identify important factors that could cause actual results to differ materially from those contained in forward looking statements or forward- looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. Hemp for Health does not undertake to update any forward-looking statement, forward-looking information or financial outlook that is incorporated by reference herein, except in accordance with applicable securities laws. We seek safe harbor.